Edition:
United Kingdom

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

1.25USD
4:57pm GMT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.25
Open
$1.30
Day's High
$1.30
Day's Low
$1.25
Volume
55,565
Avg. Vol
37,894
52-wk High
$2.92
52-wk Low
$1.17

Select another date:

Mon, Dec 11 2017

BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash

* Affimed presents data from Phase 1B combination study of AFM13 with Pembrolizumab at Ash

BRIEF-Affimed reports Q3 loss per share EUR 0.18

* Q3 earnings per share view EUR -0.17 -- Thomson Reuters I/B/E/S

BRIEF-Affimed announces Q3 financial results and corporate update conference call

* Affimed announces third quarter 2017 financial results and corporate update conference call Source text for Eikon: Further company coverage:

BRIEF-Affimed posts Q2 loss of EUR 0.18 per share

* Q2 earnings per share view EUR -0.20 -- Thomson Reuters I/B/E/S

Select another date: